Newsletter
| Promoter: | Penny Stock General | Paying Party: | UNKNOWN |
| Stocks covered: | Compensation: | Avg $ Volume for Period: |
| ERBB | $500 | UNKNOWN |
| Max Profit: 11.76 % | Gain at close: 0.00 % | |
| *We think that this promoter is a part of a group of promoters. | ||
 |
|
American Green, Inc (ERBB)
Traders, Today saw some ok dip buying opportunities but was otherwise pretty boring. So we are focusing on a new pick that has pulled back to support which could be a springboard to push higher and breakout of its recent trading range. American Green, Inc (ERBB) is a super liquid play that has recently bottomed out and is now about to breakout. We want to ride the momentum and this could be the perfect entry point. ERBB closed Friday at $0.0016. It's 200 day moving average is $0.0028 and recent highs of $0.0032 which gives ERBB a substantial upside target. ERBB became one of the first publicly traded technology companies in the cannabis industry in 2009, Now, with over 50,000 individual shareholders, more than any other company in the cannabis sector, American Green's mission is to lead the cannabis industry. Leveraging their team of professionals in cultivation, manufacturing, extraction, wholesale, retail, and community outreach, ERBB strives to develop sustainable initiatives, while increasing shareholder value, and company profit. Currently ERBB is developing medical-grade and consumer products that are based in their pure CBD isolate powder. Everything from kids’ ice cream pops to e-liquids for your vaporizer. ERBB's newest product, Clarity, is a unique, proprietary blend of cannabidiol (CBD) and Omega-3 from squid, enhancing the properties of CBD with the tried-and-true benefits of omega-3 in natural triglyceride form. ERBB's marquee products include;
US Legal Marijuana Sales To Hit $6.7 Billion In 2016 A new report by a leading marijuana industry investment and research firm found legal cannabis sales jumped 17%, to $5.4 billion, in 2015 and they will grow by a whopping 25% this year to reach $6.7 billion in total U.S. sales. The numbers are staggering, considered the first recreational dispensaries opened for business in Colorado only two years ago. ArcView Market Research recently released its fourth edition of The State of Legal Marijuana Markets report, and it includes the prediction that the legal cannabis market will see a whopping $21.8 billion in total annual sales by 2020. (By comparison, at that point, the legal marijuana market could be bigger than the National Football League, which saw roughly $12 billion of revenue last year but is aiming to reach $25 billion by 2027.) ERBB is perfectly poised, as one of the oldest, most experienced operators in the cannabis industry to take advantage of this massive projected growth.American Green Selects CR Commercial Contractors to Build a State-of-the-Art Phoenix Cultivation FacilityTEMPE, AZ--(Marketwired - Mar 8, 2016) -American Green, Inc. (OTC PINK: ERBB) today announced that it has chosen CR Commercial Contractors of Phoenix, Arizona to build our state-of-the-art facility for the cultivation of marijuana for one of American Green's licensed clients."When our Director of Design and Cultivation, Alfred Hermiz, joined the American Green team last December, his first major assignment was to develop a plan to build out our 12,000 square feet facility. In January, we began evaluating contractors with experience in marijuana cultivation build-outs as well as in medical facility construction, since this project development involves a series of clean rooms that are individually climate-controlled to help insure the production of excellent cannabis," says Jonathan Miller, American Green CEO. Out of all the companies we interviewed, CR Commercial Contractors impressed us with the quality of their work in previous projects and their relationships with the Department of Health Services who manages the medical marijuana program in Arizona." "CR Commercial Contractors is very pleased to be awarded this project," said CRCC President, Doug Terrill. "We could not be more excited to work with American Green on their new grow facility project and this expanding market sector." The 12,000 square-foot facility is expected to begin cultivation in late July after the completion of construction. At a cost of approximately $1.4 million, the facility will produce approximately 200 pounds of cannabis material per month that will be sold as a combination of flower and extracts. Alfred Hermiz adds, "Leading the American Green team on the design and build-out of what is sure to become one of Phoenix's premiere medical marijuana cultivation sites, has been a dream come true. This cultivation site will specialize in the production of high-grade medical marijuana for patients throughout Arizona." Hermiz continues, "We are planning to process many different forms of medical marijuana concentrates for patients using solvent-free methods for extraction. This will provide medical marijuana patients with the cleanest and most natural form of medical marijuana concentrates. This cultivation site can boast that it will be one of the most advanced medical marijuana grow facilities in the state -- designed and engineered to run highly energy- and water-efficient, using the highest grade equipment to provide a high-quality, consistent medicine for patients year round. I'm excited to be a member of the American Green team and to become an industry leader in how cultivation sites should be designed and operated." You can read this press release in full at http://finance.yahoo.com/news/american-green-selects-cr-commercial-133000074.htmlAs you can see ERBB is the real deal, and now its chart is telling us there is a momentum breakout to the upside. At its current price of $0.0016, and potential technical targets of $0.0028 and $0.0032, there could be 75 - 100% short term upside. Make sure you do your DD and be ready for the market open. I'll touch base in the morning with a further update. The Team
www.WallStreetGoneWild.com
Follow me on Twitter @wallstgonewild
|
|
----------------------------------------------------------------------------------- DISCLAIMER -----------------------------------------------------------------------------------
Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Before buying or selling any pick featured in this newsletter you must read our full disclaimer can be read here WallStreetGoneWild.com employees are not registered as an Investment Adviser in any jurisdiction whatsoever. WallStreetGoneWild.com may receive compensation and its employees and affiliates may own stock that they have purchased in the open market either prior, during, or after the release of the companies profile which is an inherent conflict of interest in WallStreetGoneWild.com statements and opinions and such statements and opinions cannot be considered independent. WallStreetGoneWild.com reserves the right to buy and sell shares of the profiled company on the open market before, during or after the release of the company profile. In such an event, WallStreetGoneWild.com will not update its disclaimer to reflect any shares bought or sold on the open market during the profile coverage. WallStreetGoneWild.com and its management may benefit from any increase in the share price of the profiled companies and hold the right to sell the shares bought at any given time including shortly after the release of the companies profile. WallStreetGoneWild.com may on occasion accept compensation in restricted or free-trading shares for it's marketing services of the company being profiled, and the third party that might have compensated WallStreetGoneWild.com may hold free-trading shares of the company being profiled and could very well be selling shares of the companies stock at the same time the profile is being disseminated to potential investors; this should be viewed as a definite conflict of interest and as such, the reader should take this into consideration. If WallStreetGoneWild.com ever accepts compensation in the form of restricted or free trading shares of the company being profiled and decides to sell these shares into the public market at any time before, during, or after the release of the companies profile our disclaimer will be updated accordingly reflecting the current position of those free trading shares received as compensation for our services. |
Unsubscribe | Change Subscriber Options